Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
about
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinCannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammationCannabidiol, extracted from Cannabis sativa, selectively inhibits inflammatory hypermotility in miceThe endocannabinoid system as an emerging target of pharmacotherapyAlternative targets within the endocannabinoid system for future treatment of gastrointestinal diseasesOver-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesityUlcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissueInitial insight into the function of the lysosomal 66.3 kDa protein from mouse by means of X-ray crystallographyInhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in miceEffects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated ratsInhibitory effect of palmitoylethanolamide on gastrointestinal motility in miceRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationIn vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints.Cannabinoids as novel anti-inflammatory drugs.A diet containing a nonfat dry milk matrix significantly alters systemic oxylipins and the endocannabinoid 2-arachidonoylglycerol (2-AG) in diet-induced obese miceIncreased expression of cannabinoid CB₁ receptors in Achilles tendinosis.The role of peripheral cannabinoid receptors type 1 in rats with visceral hypersensitivity induced by chronic restraint stress.Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.Differential effects of CB(1) neutral antagonists and inverse agonists on gastrointestinal motility in mice.The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitmentThe highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications.Cannabinoids alleviate experimentally induced intestinal inflammation by acting at central and peripheral receptors.Endocannabinoid signaling at the periphery: 50 years after THC.Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation.Involvement of cannabinoid receptors in gut motility and visceral perception.Neural contractions in colonic strips from patients with diverticular disease: role of endocannabinoids and substance PPrevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-TetrahydrocannabinolStructural Basis of Species-Dependent Differential Affinity of 6-Alkoxy-5-Aryl-3-Pyridinecarboxamide Cannabinoid-1 Receptor Antagonists.Potential Causes and Present Pharmacotherapy of Irritable Bowel Syndrome: An Overview.Changes in Gene Expression Patterns of Circadian-Clock, Transient Receptor Potential Vanilloid-1 and Nerve Growth Factor in Inflamed Human Esophagus.Fatty acid amide hydrolase ablation promotes ectopic lipid storage and insulin resistance due to centrally mediated hypothyroidism.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injuryCannabinoids cool the intestine.Loss of cannabinoid receptor 1 accelerates intestinal tumor growth.Endocannabinoids and the gastrointestinal tract: what are the key questions?Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.Inhibitory effect of salvinorin A, from Salvia divinorum, on ileitis-induced hypermotility: cross-talk between kappa-opioid and cannabinoid CB(1) receptors.In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat.Emerging strategies for exploiting cannabinoid receptor agonists as medicines.
P2860
Q24643876-3D4BBE6B-F55B-4FBB-84A9-A07E78B71891Q24643922-F10AA2F5-24A7-454C-BAC7-5C08A552AC52Q24645241-D9355AB5-A193-48F6-AAC7-B6DA1467F468Q24648473-E3AA1B5D-80F6-40FD-AB0B-2EE021F38C26Q26824588-52E264CD-1B80-42C9-919C-DA267713F626Q27321622-E9314142-5A58-4886-A95B-6215E10430C4Q27342536-3242AE2B-333E-46C8-A386-D4C7F909CD5CQ27657154-DDCAF40C-D8AE-42F4-9890-2D9A3890CCA2Q28258759-2DBA2CC7-6AD8-4F59-9ADD-44D9A1748D43Q28271665-9F511136-45E0-4755-BAF1-E5E70CC31709Q28362696-D7A4B9A5-831C-4326-A215-9B213E2921BEQ30357558-2508C8C0-17D1-4789-A1A5-B69966E44236Q33304983-66FEF021-DA1B-4C52-9DE4-3910ABE42857Q33688381-393B5AA2-1CB2-4952-9E0F-0148A491266DQ33799861-1BF57B82-768D-4CB9-B158-259835C8A295Q34023999-A515EBAB-E039-44CC-8A6C-F8D0E2808CFAQ34028431-67A306D4-D741-4A30-93C2-71546990D120Q34078746-1F59F468-1547-48C7-8A3D-7400857EA684Q34145142-AE06460C-BA9E-4415-89B0-B97AFA4332C0Q34199383-EDDFAC79-C6F8-477C-85F5-413C50CF5337Q35122796-48F5FC4F-DB62-4422-826B-EAE7D9D343A0Q35294138-D8373DE6-A896-42EE-AD71-71B450D78787Q35572176-4026C458-008B-4925-9B94-21D4815598C0Q35693020-5FAD1CDA-BA94-4A5B-8433-AC2282F3CEAEQ35752224-00ED86CE-32B1-4F54-93E8-7AABD0614CF7Q35760666-8FB4C9D3-BC9D-4B85-96BD-A9F766EBBB1BQ35860227-00708552-BE87-41BF-899A-E22D983D1D4AQ35897867-08DF38C1-79CA-45C0-BD56-794C969CA239Q35971357-3D17D668-1AF1-4E33-B4DD-DBE67202EBBEQ36026799-30D958E4-76A9-4ADC-A0E1-AA88D2288BDFQ36236384-14E99DEF-B431-4DE8-9414-C54C99C1DE52Q36341688-CD8A83B2-D6C7-4C28-9D54-4FA8906E1643Q36795890-382FF699-9FCE-40F7-BC71-4741F2A8CF9CQ36837926-AECB98B1-978F-4098-889A-30CADC4BC3BDQ36922627-E990C473-DB3A-42F9-B020-76A870A5D907Q36927486-9AB8344E-116F-4C5E-9ABF-CFA64E8DF40EQ36947747-71C40876-E956-4609-AF8B-6F36B8151A03Q36977483-E6E96903-8D65-4275-B725-842A776AB7E2Q37032490-0F5357A6-5A9F-444D-8628-6FA81392CD82Q37230665-3F7F6C39-6B29-4B39-BF85-A466BFB648F1
P2860
Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@ast
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@en
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@nl
type
label
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@ast
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@en
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@nl
prefLabel
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@ast
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@en
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@nl
P2093
P2860
P921
P356
P1476
Cannabinoid CB1-receptor media ...... del of intestinal inflammation
@en
P2093
V Di Marzo
P2860
P304
P356
10.1038/SJ.BJP.0704293
P407
P577
2001-10-01T00:00:00Z